Phase II Study of Monthly Pasireotide LAR (SOM230C) for Recurrent or Progressive Meningioma.

Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.29.15_suppl.2040
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Phase II Trials of Erlotinib or Gefitinib in Patients With Recurrent Meningioma

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2009English

Phase II Study of Bevacizumab and Pemetrexed for Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2013English

Meningioma Imitating Progressive Aphasia

Journal of the Korean Neurological Association
2020English

A Phase II Study of Axalimogene Filolisbac for Patients With Previously Treated, Unresectable, Persistent/Recurrent Loco-Regional or Metastatic Anal Cancer

Oncotarget
Oncology
2020English

Phase II Evaluation of Intravenous Vinorelbine (Navelbine) in Recurrent or Refractory Pediatric Malignancies: A Children's Oncology Group Study

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2009English

Phase II Evaluation of Dasatinib in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study

Gynecologic Oncology
GynecologyOncologyObstetrics
2012English

Erratum To: Pasireotide LAR Maintains Inhibition of GH and IGF-1 in Patients With Acromegaly for Up to 25 Months: Results From the Blinded Extension Phase of a Randomized, Double-Blind, Multicenter, Phase III Study

Pituitary
EndocrinologyMetabolismDiabetes
2015English

A Retrospective Study on Combination Therapy With Ifosfamide, Adriamycin and Cisplatin for Progressive or Recurrent Uterine Sarcoma

Molecular and Clinical Oncology
Cancer ResearchOncology
2014English

A Phase II Evaluation of Lapatinib in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study

Gynecologic Oncology
GynecologyOncologyObstetrics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy